tirzepatide and mounjaro Mounjaro (Tirzepatide): Raising the Bar

Macrophages are usually differentiated into M1 or M2 subtypes, with the M1 type promoting an acute inflammatory response in tumor cells and the M2 type promoting chronic inflammation, which in turn leads to immunosuppression and promotes tumor growth (36)

Why consider switching from semaglutide to tirzepatide

Reduction in headache was a consistent finding across the studies using GLP-1 RAs

Rituximab treatment of myasthenia gravis: a systematic review

Researchers are finding that GLP-1 agonists influence multiple pathways involved in inflammation, cardiovascular health, mood, motivation and rewardbenefits that appear to extend beyond the downstream effects of weight loss alone